18
M. Poša et al. / Steroids 86 (2014) 16–25
from ethylidene on C3), 115.10 and 115.19 (CH from ethylidene on
C7), 137.89 (C7), 138.99 and 139.03 (C3), 174.79 (C24), 213.68 (C12).
HRMS: calculated for C28H42O3 (2M+H)+: 853.63407; measured:
853.63382. IR (cmꢁ1): 757, 1708, 2931.
2.5. Determination of haemolytic potential
Erythrolysis was determined from citrate rabbit blood accord-
ing to Bowe et al. [11].
2.2. 3a-Hydroxy-12-oxo-7(E)-ethylidene-5b-cholanoic acid (6)
2.6. Determination of bile salt cholesterol solubilising capacity
The compound (6) was prepared according to the method
described above. Crude product was purified by flash column chro-
matography (toluene/EtOAc 1:1), and compound (6) was obtained
(11%, mp 189–191 °C after crystallisation from acetone/hexane
1:1), as fine white needles.
Solubilisation of cholesterol by sodium salts of analysed bile
acids was determined using method of Poša et al. [8]. The amount
of dissolved cholesterol from water solution was determined by
enzymatic method with cholesterol oxidase (Reanal, Budapest),
measuring absorbance at 500 nm on Agilent 8453 spectrophotom-
eter, using distilled water as blank. The bile salt solubilising capac-
ity (CChm) is expressed as the number of moles of dissolved
cholesterol monohydrate per mole of bile acid (mole fraction of
dissolved cholesterol).
1H NMR (500 MHz, DMSO-d6, ppm): 0.72 (d, J = 5.9 Hz, 3H from
C21 methyl group), 0.97 (m, 2H), 0.98 (s, 3H, from C18 methyl
group), 1.09 (s, 3H, from C19 methyl group), 1.50 (d, J = 6.6 Hz,
3H, from ethylidene methyl group), 3.35 (m, 1H, from C3), 5.19
(q, J = 6.8 Hz, 1H, CH from ethylidene). 13C NMR (125 MHz,
DMSO-d6, ppm): 11.73 (C18), 13.18 (CH3 from ethylidene), 18.82
(C21), 23.06 (C19), 25.77 (C15), 27.36, 30.12, 30.54, 31.32, 31.59,
34.73, 35.26, 36.17, 36.53, 38.11 (C11), 42.24, 43.93, 45.70, 47.05
(C9), 53.82 (C14), 56.69, 69.40 (C3), 115.09 (CH from ethylidene),
138.40 (C7), 175.20 (C24), 214.71 (C12). HRMS: calculated for
2.7. Molecular descriptor and data treatment
The bile acid molecule structures were preoptimised with the
Molecular Mechanics Force Field procedure included in Hyper-
chem version 7.5, and the resulting geometries were further sub-
mitted to the semi-empirical method Parametric Method-3 using
the Fletcher–Reeves algorithm and a gradient norm limit of
0.009 kcal/Å. Using Dragon 6.0 software next molecular descriptors
were generated: unsaturation count (Uc), unsaturation index (Ui),
hydrophilic factor (Hy), Ghose–Crippen molar refractivity (AMR),
topological polar surface area using O polar contributions (TPSA),
Moriguchi octanol–water partition coefficient (MlogP), squared
Moriguchi octanol–water partition coefficient (MlogP2), Ghose–
Crippen octanol–water partition coefficient (ALogP), squared
Ghose–Crippen octanol–water partition coefficient (ALogP2), total
surface area from P_VSA-like descriptors (SAtot), surface area of
acceptor atoms from P_VSA-like descriptors (SAacc), surface area
of donor atoms from P_VSA-like descriptors (SAdon), McGowan
volume (Vx), van der Waals volume from McGowan volume
(VvdwMG), van der Waals volume from Zhao–Abraham–Zissimos
equation (VvdwZAZ), packing density index (PDI), Verhaar Fish
base-line toxicity from MLOGP (BLTF96), valence connectivity
index of order 0 (X0v), valence connectivity index of order 1
(X1v), valence connectivity index of order 2 (X2v) and valence con-
nectivity index of order 3 (X3v) [27]. For calculating principle com-
ponents, NIPALS [28] algorithm Statistica 8 software was used.
C
26H40O4 (M+NH4)+: 434.32649; measured: 434.32439. IR
(cmꢁ1): 3376, 2931, 1705, 753.
2.3. 3a,12a-Dihydroxy-7(E)-ethylidene-5b-cholanoic acid (7)
The compound (7) was prepared according to the method
described for (4a,b) and (5a,b). Crude product was purified by flash
column chromatography (CH2Cl2/acetone 5:1), and (7) was
obtained as colourless oil (8.2%).
1H NMR (500 MHz, DMSO-d6, ppm): 0.61 (s, 3H, H from C18
methyl group), 0.92 (d, J = 6.5 Hz, 3H, H from C21 methyl group),
0.97 (s, 3H, H from C19 methyl group), 1.52 (d, J = 6.6 Hz, 3H, CH3
from ethylidene), 3.30–3.40 (m, 1H, H from C3 CHOH group), 3.82
(s, 1H, H from C12 CHOH group), 5.23 (q, J = 6.5 Hz, 1H, CH from
ethylidene). 13C NMR (125 MHz, DMSO, ppm): 12.71 (C18), 12.88
(CH3 from ethylidene), 17.17 (C21), 23.37 (C19), 24.71 (C15), 27.18,
28.59 (C11), 30.09, 31.02, 31.41, 31.49, 34.76, 34.87, 35.19, 35.81,
36.14, 40.63, 42.45, 44.64, 45.65, 46.17, 69.54 (C3), 70.32 (C12),
113.63 (CH from ethylidene), 139.63 (C7), 175.32 (C24). HRMS: cal-
culated for C26H42O4 (2M+H)+: 837.62390; measured: 837.62277.
IR (cmꢁ1): 756, 1709, 2869, 2940, 3402.
2.4. Reverse phase HPLC method
3. Results and discussions
The HPLC system Agilent 1100 Series, equipped with degasser,
binary pump, automatic injector and DAD detector with software
system for data processing Agilent Chem Station was used and
the analyses were performed on a reversed-phase C-18 column:
3.1. Reactions of Wittig olefination of bile acid oxo derivatives
Wittig olefination (with: ethylidenetriphenylposphorane) of
3,7,12-trioxo-5b-cholanoic acid (1) gives mixture of 3(EZ)-ethyli-
dene-7,12-dioxo-5b-cholanoic acid (4) and 3(EZ),7(E)-diethylid-
ene-12-oxo-5b-cholanoic acid (5). Monoethylidene product (4)
consists of equimolar amounts of E and Z isomers, and diethylidene
product (5) is consisted of equimolar amounts of 3E,7E- and
3Z,7E-isomers. We have found that 7,12-dioxolithocholic acid (2)
regio and stereoselectively gives 7(E)-ethylidene product (6), while
7-oxodeoxycholic acid (3) in same reaction conditions yields ster-
eoselective product (7) (Fig. 1). Butylidenephosphorane failed to
react in the same reaction conditions. Stereochemistry on C7 was
determined using various NMR experiments which supports E con-
figuration. In ROESY spectrum of 5, 6 and 7 vinylic hydrogen of C7
ethylidene, has cross peaks that originate from through space
Eclipse Plus C18 (250 mm ꢀ 3 mm, 5
lm, 250 Å) column (Zorbax
SD). The mobile phase was 0.01 M phosphate buffer/metha-
nol = 70:130 (v/v) maintained at pH 7 and the injection volume
was 10 lL. Solutions of bile acids and their derivatives in mobile
phase were prepared in concentration of 1 mg/ml. All separations
were performed isocratically at a flow rate of 1 ml/min and a col-
umn temperature changing from 20 to 45 °C. The detection was
performed at 210 nm [26]. The HPLC capacity (retention) factor
(k) was calculated from the eluted peak retention time (t):
tx ꢁ t0
k ¼
t0
where tx and t0 are the retention times of the bile acids and the
unretained solvent front respectively.
interaction with
materials).
aH on C14 and aH on C15. (Fig. 2 and Supporting